# From Cosmetic Abuse to Clinical Mismanagement: A National Simulated Patient Study Assessing Community Pharmacists’ Stewardship of Topical Corticosteroids in Jordan

**Authors:** Derar H. Abdel-Qader, Abdullah Albassam, Esra’ Taybeh, Nadia Al Mazrouei, Rana Ibrahim, Reham Aljalamdeh, Salim Hamadi, Alia Saleh, Sahar Jaradat, Shorouq Al-Omoush

PMC · DOI: 10.3390/pharmacy14010031 · Pharmacy · 2026-02-09

## TL;DR

This study evaluates how Jordanian community pharmacists handle steroid creams, finding they are more cautious with children but often illegally provide steroids for cosmetic use.

## Contribution

The study introduces a simulated patient approach to assess pharmacists' adherence to guidelines in diverse clinical scenarios involving topical corticosteroids.

## Key findings

- Pharmacists were most cautious in pediatric cases but frequently dispensed steroids for cosmetic use.
- Chain pharmacies and pharmacists with advanced degrees were more likely to follow safety guidelines.
- High workload reduced adherence to safe practices.

## Abstract

Background: Topical Corticosteroids (TCS) are potent therapeutic agents associated with severe local and systemic adverse effects if misused. In Jordan, the unauthorized supply of TCS for cosmetic purposes and the mismanagement of dermatological conditions remain significant public health concerns. This study utilized a repeated-measures simulated patient (SP) methodology to evaluate community pharmacists’ stewardship of TCS across a spectrum of clinical risks. Methods: A national cross-sectional study was conducted across 380 randomly selected community pharmacies in Jordan. Each pharmacy received four covert visits (N = 1520) corresponding to four distinct clinical scenarios representing different risk levels: cosmetic whitening, acne management, fungal infection, and pediatric diaper rash. The primary outcome was appropriate Practice, defined as the refusal to dispense unsafe medication or the provision of evidence-based alternatives. Results: Stewardship behavior varied significantly by clinical context (p < 0.001). Pharmacists demonstrated a hierarchy of safety, adhering to guidelines most strictly in the Pediatric scenario (82.1% appropriate refusal) but frequently abandoning safety standards in the Cosmetic scenario (30.0% appropriate refusal). Notably, 70.0% of pharmacists dispensed potent steroids for facial whitening, and 26.1% voluntarily offered to compound unauthorized steroid mixtures (Khaltat). In the acne scenario, 52.1% dispensed the contraindicated TCS, while only 37.9% appropriately switched the patient to an evidence-based alternative. In the fungal scenario, 60.0% failed to visually inspect the lesion, leading to a 40.0% rate of inappropriate TCS dispensing. Multivariable regression indicated that pharmacists working in chain pharmacies (aOR: 2.15, 95% CI: 1.68–2.75) and those holding advanced degrees (PharmD/MSc) (aOR > 1.38) were significantly more likely to practice appropriate TCS stewardship. High workload (>200 prescriptions/day) was a significant barrier to safety (aOR: 0.55). Conclusions: Community pharmacists in Jordan exhibited selective TCS stewardship, demonstrating high vigilance for pediatric safety, but widespread illegal practice regarding cosmetic misuse and differential diagnosis that may be unethical. The study results warrant the need for further urgent research to understand why these practices are occurring and how best to address them.

## Linked entities

- **Diseases:** acne (MONDO:0011438)

## Full-text entities

- **Diseases:** dermophytic infection (MESH:D007239), acneiform conditions (MESH:D017486), POM (MESH:D019966), steroid (MESH:D016114), tinea incognito (MESH:C000656845), ochronosis (MESH:D009794), Diaper Rash (MESH:D003963), dermatologic disease (MESH:D000168), atrophy (MESH:D001284), hyperkeratosis (MESH:D017488), HPA axis suppression (MESH:C566610), tinea (MESH:D014005), inflammation (MESH:D007249), injury to (MESH:D014947), striae (MESH:D057896), telangiectasias (MESH:D013684), inflammatory dermatoses (MESH:D012871), rosacea (MESH:D012393), Fungal Infection (MESH:D009181), Cushing's Syndrome (MESH:D003480), erythema (MESH:D004890), acne (MESH:D000152), itch (MESH:D011537), bacterial (MESH:D001424), rash (MESH:D005076), lesion (MESH:D009059), dermatitis (MESH:D003872), allergy (MESH:D004342)
- **Chemicals:** hydroquinone (MESH:C031927), Class I steroid (-), benzodiazepines (MESH:D001569), Adapalene (MESH:D000068816), Dermovate (MESH:D002990), counter (MESH:C012568), steroid (MESH:D013256), Benzoyl peroxide (MESH:D001585), retinoid (MESH:D012176)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921794/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921794/full.md

---
Source: https://tomesphere.com/paper/PMC12921794